Clinical Trial Update: Bazedoxifene/Conjugated Estrogens (BZA/CE) Improvement of Metabolism (BIM) [Phase 4]

View source ↗

Summary

Phase 4 trial update on Bazedoxifene/Conjugated Estrogens (BZA/CE) assessing improvement in metabolism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glucose Homeostasis
• Obesity
• Postmenopausal Symptoms

Drugs mentioned

• Bazedoxifene/Conjugated Estrogens (bazedoxifene/conjugated estrogens)

Snippet

Sponsor: Tulane University Health Sciences Center | Conditions: Obesity, Glucose Homeostasis | Phase 4 | Status: COMPLETED | Results posted: 2023-06-26